Met Life Investment Management, LLC Twist Bioscience Corp Transaction History

Met Life Investment Management, LLC

$14.7 Billion
Q1 2024

A detailed history of Met Life Investment Management, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 30,046 shares of TWST stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

30,046

Holding current value

$1.42 Million

% of portfolio

0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$32.28 - $41.5 $969,884 - $1.25 Million	30,046 New	30,046 $1.03 Million
Q2 2023 Apr 29, 2024	BUY	$11.49 - $20.46 $341,138 - $607,457	29,690 New	29,690 $607,000
Q1 2023 May 09, 2024	BUY	$14.6 - $30.9 $433,474 - $917,421	29,690 New	29,690 $448 Million
Q1 2022 May 10, 2024	BUY	$38.58 - $83.27 $1.15 Million - $2.47 Million	29,690 New	29,690 $1.47 Million
Q1 2022 Mar 22, 2023	BUY	$38.58 - $83.27 $513,422 - $1.11 Million	13,308 Added 81.24%	29,690 $1.47 Million

Q1 2022 May 12, 2022	BUY	$38.58 - $83.27 $513,422 - $1.11 Million	13,308 Added 81.24%	29,690 $1.47 Million
Q4 2021 Jun 21, 2023	SELL	$75.47 - $135.88 $1 Million - $1.81 Million	-13,308 Reduced 44.82%	16,382 $1.27 Million
Q3 2021 May 17, 2024	SELL	$95.64 - $131.48 $101,378 - $139,368	-1,060 Reduced 6.08%	16,382 $1.75 Million
Q3 2021 Jun 21, 2023	SELL	$95.64 - $131.48 $1.27 Million - $1.75 Million	-13,308 Reduced 44.82%	16,382 $1.75 Million
Q3 2021 Mar 22, 2023	SELL	$95.64 - $131.48 $101,378 - $139,368	-1,060 Reduced 6.08%	16,382 $1.75 Million
Q3 2021 Nov 15, 2021	SELL	$95.64 - $131.48 $101,378 - $139,368	-1,060 Reduced 6.08%	16,382 $1.75 Million
Q2 2021 Jun 21, 2023	SELL	$88.13 - $142.06 $1.08 Million - $1.74 Million	-12,248 Reduced 41.25%	17,442 $2.32 Million
Q1 2021 May 17, 2024	SELL	$105.48 - $207.97 $1.33 Million - $2.62 Million	-12,604 Reduced 41.95%	17,442 $2.16 Million
Q1 2021 Jun 26, 2023	SELL	$105.48 - $207.97 $1.29 Million - $2.55 Million	-12,248 Reduced 41.25%	17,442 $2.16 Billion
Q1 2021 Mar 22, 2023	BUY	$105.48 - $207.97 $421,603 - $831,256	3,997 Added 29.73%	17,442 $2.16 Million
Q1 2021 May 14, 2021	BUY	$105.48 - $207.97 $421,603 - $831,256	3,997 Added 29.73%	17,442 $2.16 Million
Q4 2020 Jun 22, 2023	SELL	$76.64 - $167.89 $1.25 Million - $2.73 Million	-16,245 Reduced 54.72%	13,445 $1.9 Million
Q3 2020 Jun 26, 2023	SELL	$45.46 - $78.79 $738,497 - $1.28 Million	-16,245 Reduced 54.72%	13,445 $1.02 Million
Q2 2020 May 24, 2024	SELL	$26.4 - $45.3 $438,266 - $752,025	-16,601 Reduced 55.25%	13,445 $609 Million
Q2 2020 Jun 26, 2023	SELL	$26.4 - $45.3 $428,868 - $735,898	-16,245 Reduced 54.72%	13,445 $609,000
Q2 2020 Mar 22, 2023	BUY	$26.4 - $45.3 $47,863 - $82,128	1,813 Added 15.59%	13,445 $609,000
Q2 2020 Aug 14, 2020	BUY	$26.4 - $45.3 $47,863 - $82,128	1,813 Added 15.59%	13,445 $609,000
Q1 2020 Jul 12, 2023	SELL	$19.71 - $35.15 $355,923 - $634,738	-18,058 Reduced 60.82%	11,632 $355,000
Q1 2020 Mar 22, 2023	BUY	$19.71 - $35.15 $27,396 - $48,858	1,390 Added 13.57%	11,632 $355,000
Q1 2020 May 15, 2020	BUY	$19.71 - $35.15 $27,396 - $48,858	1,390 Added 13.57%	11,632 $356,000
Q4 2019 Jul 12, 2023	SELL	$21.0 - $26.48 $408,408 - $514,983	-19,448 Reduced 65.5%	10,242 $215,000
Q3 2019 Jul 12, 2023	SELL	$23.72 - $33.99 $461,306 - $661,037	-19,448 Reduced 65.5%	10,242 $244,000
Q3 2019 Mar 22, 2023	SELL	$23.72 - $33.99 $461,306 - $661,037	-19,448 Reduced 65.5%	10,242 $244,000
Q3 2019 Nov 14, 2019	BUY	$23.72 - $33.99 $242,940 - $348,125	10,242 New	10,242 $245,000
Q2 2019 Jul 12, 2023	SELL	$21.74 - $33.2 $422,799 - $645,673	-19,448 Reduced 65.5%	10,242 $297 Million

Others Institutions Holding TWST

# of Institutions

252

Shares Held

65.9M

Call Options Held

247K

Put Options Held

203K

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.67B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Twist Bioscience Corp Transaction History